R. The MAFB transcription factor impacts islet ␣-cell function in rodents and represents a unique signature of primate islet ␤-cells.
islets until MafA was comprehensively expressed in this cell population. We propose that MafA compensates for the absence of MafB in MafB ⌬panc mice, which is supported by the death of MafAB ⌬panc mice soon after birth from hyperglycemia. However, glucose-induced glucagon secretion was compromised in adult MafB ⌬panc islet ␣-cells. Based upon these results, we conclude that MafB is only essential to islet ␣-cell activity and not ␤-cell. Interestingly, a notable difference between mice and humans is that MAFB is coexpressed with MAFA in adult human islet ␤-cells. Here, we show that nonhuman primate (NHP) islet ␣-and ␤-cells also produce MAFB, implying that MAFB represents a unique signature and likely important regulator of the primate islet ␤-cell. diabetes; transcription factor; nonhuman primate; islet; ␣-cell PANCREATIC ␣-AND ␤-CELLS are major hormone-producing cell types of the islets of Langerhans. The hormones secreted by these cells act in a counterregulatory manner to control the glucose concentration in the bloodstream, with ␣-cell-produced glucagon raising and ␤-cell-produced insulin lowering levels. Loss or dysfunction of islet ␤-cells leads to insulin insufficiency and hyperglycemia in type 1 (T1DM) and type 2 diabetes mellitus (T2DM) (44) . The healthcare costs associated with diabetes care are enormous and rising, and consequently, efforts are focused on developing therapies to minimize these complications, including developing ␤-like cells from human embryonic stem cells or induced-pluripotent stem cells (26, 33, 35) .
Identifying the key factors that mediate islet ␣-and ␤-cell formation is essential to understanding T1DM and T2DM disease processes and for improving cell-based interventions. Notably, many transcription factors serve as critical regulators of islet cell development and function (32) , with alterations in their activity contributing to ␣-and ␤-cell dysfunction in T2DM (19) . For example, pancreatic duodenal homeobox-1 (Pdx1) is expressed in all pancreatic progenitors before being restricted to islet ␤-cells. Mice (2, 25, 30) and humans (42) completely lacking this transcription factor fail to develop a pancreas, whereas cell identity is severely compromised upon conditional deletion from adult mouse islet ␤-cells (2) . Ngn3, which is produced later during embryogenesis, is essential for the differentiation of endocrine progenitor cells into each of the hormone ϩ cell subtypes [i.e., ␤-and ␣-cells, ␦-cells (which secrete somatostatin), pancreatic polypeptide cells (which secrete pancreatic polypeptide), and ε-cells (which secrete ghrelin)] (16, 17) . MafA and MafB are unusual in not being expressed until the onset of hormone ϩ cell formation (21) , with MafA exclusively in insulin ϩ cells (27, 29) and MafB also in glucagon ϩ cells (6) . MAFA, MAFB, and PDX1 levels were specifically decreased in human T2DM islet ␣-and ␤-cells, and these factors have been proposed to be major contributors to islet cell dysfunction (19) . Interestingly, the combination of Pdx1, Ngn3, and MafA was sufficient to convert nonendocrine cells to ␤-like cells in mice (12, 47) , whereas adenovirus-driven expression of MafA was able to induce glucose-stimulated insulin secretion (GSIS) in neonatal rat islets (1) . Collectively, these data not only illustrate the stage-specific activities of key islet transcription factors but also provide support for MafA and MafB contributing to events involved in ␤-cell formation.
MafB Ϫ/Ϫ pancreata exhibited an ϳ50% loss of insulin ϩ and glucagon ϩ cells by embryonic day (E)15.5, whereas expression of key ␤-cell-enriched transcription factors was reduced by E18.5 (e.g., Pdx1, Nkx6.1). Islet ␤-cell-specific MafA production correlated with insulin ϩ cell formation in the MafB Ϫ/Ϫ animals, and there was no reduction in total endocrine cell number (3). Although these results strongly suggested that MafB was a key islet cell regulator in vivo, this could not be assessed postnatally since MafB Ϫ/Ϫ mice die at birth due to renal failure and central apnea (7, 37 (41) ] MafAknockout mice. However, these MafA mutants postnatally develop glucose intolerance, changes in islet cell architecture, reduced ␤-cell mass, and compromised ␤-cell gene expression (5, 22, 41, 46) . Because MafB is not produced in rodent ␤-cells after birth (6), these results indicated that MafB was necessary for ␤-cell development, and MafA was essential to adult islet ␤-cell function.
In contrast to mouse ␤-cells, MAFB is coexpressed with MAFA in adult human islet ␤-cells (14) . However, the expression and distribution of other islet-enriched transcription factors (i.e., PDX1, NKX6.1) are similar between rodents and humans (14) . Because islet-enriched transcription factors profoundly influence mouse islet cell function and identity, the distinctive human MAFB expression pattern could be contributing to dissimilarities in islet cell characteristics between humans and mice (14) . This hypothesis derives from the biochemical and functional differences reported for the MafA and MafB dimeric activators (20) . For example, misexpression of MafA in a mouse islet ␣-cell line activated insulin gene expression (4), whereas MafB induced glucagon in a mouse ␤-cell line (6) . Similarly, only MafA stimulated insulin production in chick in ovo electroporation assays, although exchanging the MafB COOH-terminal DNA-binding dimerization (basic leucine zipper) spanning region with that of MafA enabled insulin induction (4) .
Here, we produced pancreas-wide deletion mutants of MafB (MafB ⌬panc ) and MafA/B (MafAB ⌬panc ) to compare the postnatal contributions of these transcription factors to islet cell formation and function. Elevated blood glucose levels were observed just after birth in MafB ⌬panc mice, which soon resolved upon comprehensive production of MafA within the insulin ϩ cell population. In addition, there was a profound reduction in glucagon secretion levels from adult islet ␣-cells. In contrast, MafAB ⌬panc mice died from hyperglycemia shortly after birth due to loss of insulin ϩ cells. These results demonstrated that MafB primarily affects mouse islet ␣-cell function and not ␤-cell activity. Notably, MAFB was coexpressed with MAFA in nonhuman primate (NHP) islet ␤-cells, suggesting that this factor imparts distinct control properties in primates. The significance of MAFB to primate ␤-cells is supported by the recent observation showing that knockdown of this transcription factor suppressed GSIS in the human EndoC-␤H1 ␤-cell line (41) . Islet isolation conditions. Two-week-old mouse pancreata were partially digested with 1 mg/ml collagenase, followed by handpicking of islets; adult islets were collected as described previously (22) . Cause of death was head trauma (n ϭ 11), neurological events (stroke, subarachnoid hemorrhage, etc.; n ϭ 10), anoxia (n ϭ 2), or unknown (n ϭ 7). The cold ischemia time before pancreas isolation was 9.9 Ϯ 1.1 h (range: 1.5-24.9 h). Human and NHP islets were handpicked on the day of arrival as described (14) . All studies with human and NHP islets were in compliance with the Vanderbilt Institutional Animal Care and Review Board Committee.
MATERIALS AND METHODS

Generation
RNA analysis. Quantitative real-time PCR was performed on RNA isolated from NHP, human, and mouse (e.g., C57BL/6J) islets (14) as well as MafB ⌬panc and MafB fl/fl islets (22), using previously described conditions. Preloaded arrays (Applied Biosystems) of 16 genes were used to determine expression levels in NHP, human, and mouse islets in Fig. 7 , with the 18S/18s, ACTB/ActB, TFRC/Tfrc, and TBP/Tbp genes used for normalization. Primer sequences are available upon request. Primer efficiency was similar between species as guaranteed by the manufacturer and verified empirically. For assessing the data, the Minimum Information for Publication of Quantitative Real-Time PCR Experiments was followed (10) .
Tissue collection and immunohistochemistry. The paraformaldehyde-embedding conditions for NHP, human, and mouse islets (14) as well as mouse pancreata (22) have been described. Primary antibodies utilized for mouse sections were as follows: insulin (guinea pig; Dako), glucagon (mouse; Sigma), glucagon (rabbit; Linco), MafB (rabbit; Bethyl), MafA (rabbit; Novus), Pax6 (rabbit; Covance), Pdx1 (goat; provided by Chris Wright, Vanderbilt), Nkx6.1 (rabbit; ␤-Cell Biology Consortium), Slc30A8 (rabbit; Pierce), Glut2 (goat; Santa Cruz Biotechnology), ghrelin (goat; Santa Cruz Biotechnology), Ki-67, and (mouse; BD Pharmingen). Primary antibodies used for NHP and human sections were as follows: insulin (guinea pig; Dako or Linco), glucagon (mouse; Sigma), glucagon (rabbit; Cell Signaling Technology), MafB (rabbit; Novus or Bethyl), MafA (rabbit; Novus), and somatostatin (goat; Santa Cruz Biotechnology). Briefly, the primary antibody-antigen complex was visualized on 6-m sections by immunofluorescence using secondary antibodies conjugated with Cy2, Cy3, or Cy5 fluorophores (1:500; Jackson ImmunoResearch, West Grove, PA). Nuclear costaining was conducted with DAPI Fluoromount G (Southern Biotech). Immunofluorescent images were acquired with a Zeiss LSM510 confocal microscope or a Zeiss Axioimager M2 microscope.
Islet cell population analysis. Mouse pancreatic sections at 133-, 288-, and 354-m spacing were prepared from E15.5, postnatal day 1 (P1), and 2-wk-old samples, respectively. Insulin ϩ , glucagon ϩ , Pax6 ϩ , Pdx1 ϩ , and Nkx6.1 ϩ cell images were counted manually and divided by the total number of pancreatic DAPI ϩ nuclei. At least 10,000, 20,000, and 100,000 pancreatic nuclei were counted for E15.5, P1, and 2-wk-old samples, respectively. Intraperitoneal glucose tolerance test. Three-, six-, and eight-wkold mice (n Ն 7) were fasted for 6 h, and blood glucose level from tail blood was determined using a FreeStyle glucometer (Abbott Diabetes Care). The mice were then weighed, and 2 mg dextrose/g body wt (Fisher Biotech) in sterile PBS was injected intraperitoneally. Blood glucose levels were measured at 0, 15, 30, 60, 90, and 120 min postinjection. Fed blood glucose levels were determined prior to fasting.
Stimulated hormone secretion. Handpicked islets from 2-and 8-wk-old MafB ⌬panc and control MafB fl/fl mice were cultured overnight in RPMI 1640, 10% FBS, and penicillin-streptomycin supplemented with 5.6 (for insulin secretion) or 11 mM D-glucose (for glucagon secretion). The next day, islets were subjected to hormone secretion conditions in KRBH buffer (1.25 mM CaCl 2, 0.6 mM MgS04, 0.6 mM KH2PO4, 2.4 mM KCl, 64.0 mM NaCl, 20 mM HEPES, pH 7.9, and 5 mM NaHCO3) with either 2.8 or 16.7 mM glucose for insulin secretion and 1 mM glucose or 1 mM glucose plus 10 mM arginine for glucagon secretion. Following 45 min of stimulation at 37°C, secretion media were collected and islets lysed in 1.5% HCl and 70% ethanol. Secreted (media) and cell content hormone levels were determined by ELISA (insulin, ALPCO; glucagon, RayBiotech). Hormone secretion was expressed as the percentage of total hormone content. The NHP, human, and mouse perifusion studies were conducted in the Vanderbilt Islet Isolation and Analysis Core under standard conditions (14) , using as baseline 5.6 mM glucose and 16.7 mM glucose alone or with 500 M 3-isobutyl-1-methylxanthine (IBMX) for stimulating insulin secretion.
Statistics. Statistical significance was determined by one-way ANOVA between NHP, human, and mouse samples. The data with MafAB ⌬panc and MafB ⌬panc mice were presented as means Ϯ SE, and statistical significance assessed by comparing data points between mutants and controls using the Student two-tailed unpaired t-test.
RESULTS
Loss of MafB alone results in delayed ␤-cell maturation.
The role of MafB in postnatal ␣-and ␤-cells remains unclear, since MafB Ϫ/Ϫ mice die at birth (37) . As a result, floxed MafB mice were crossed with early pancreas-driven Pdx1-Cre (MafB ⌬panc ) transgenic mice to determine the specific influence on postnatal islet cells. MafB was effectively removed from MafB ⌬panc ␣-and ␤-cells by E15.5 . B: reduction in embryonic day (E)15.5 MafB ⌬panc insulin ϩ and glucagon ϩ cell numbers is ameliorated within 2 wk after birth. Approximately 10,000 and 100,000 pancreatic nuclei were counted at E15.5 and 2 wk, respectively (n ϭ 3). C: MafB ⌬panc animals exhibit normal glucose tolerance by 3 wk. Glucose tolerance tests were performed at 3, 6, and 8 wk (n ϭ 11-21 , and there was no effect on mortality. However, MafB ⌬panc mice were mildly hyperglycemic at P1, a situation that resolved by 2 wk (Fig. 1A) . Hormone ϩ and pan-endocrine Pax6 ϩ cell numbers were quantified at E15.5 and 2 wk to determine whether insulin ϩ and/or glucagon ϩ cell production was impacted in MafB ⌬panc mice. Although there was no change in the Pax6 population that marks all islet cells, there was a significant decrease in the insulin ϩ (ϳ75%) and glucagon ϩ (ϳ50%) cell numbers at E15.5 (Fig. 1B) . These results were expected from the analysis of the MafB Ϫ/Ϫ mutant (3).
Notably, MafB ⌬panc insulin ϩ and glucagon ϩ cell numbers were indistinguishable from wild-type littermate controls by 2 wk (Fig. 1B) . However, the islet ␤-cell-enriched Pdx1 transcription factor was aberrantly detected in hormonenegative cells in earlier P1 MafB ⌬panc samples, which was resolved by 2 wk (Fig. 2, A and B) . Since MafB is normally produced in embryonic insulin ϩ cells prior to MafA (6, 27), we examined whether MafA or another related large Maf transcription factor, c-Maf (28, 29) , could be acting in a compensatory manner in MafB ⌬panc mice. MafA was detected only in MafB ⌬panc insulin ϩ cells (Fig. 2, A and C) , whereas c-Maf was undetectable in both mutant and control Fig. 2 samples (data not shown). Moreover, the inability to detect a change in the Ki-67 ϩ cell numbers between MafB ⌬panc and MafB fl/fl insulin ϩ cells at P1 suggests that enhanced proliferation did not lead to recovery of the ␤-cell population (Fig. 2D) . Considering the importance of MafA to mouse ␤-cell function after birth (22, 46) , we conclude that MafA compensates for MafB in MafB ⌬panc mice, with the later expression of MafA influencing the delayed production of insulin ϩ cell numbers and ␤-cell function. In support of this conclusion, the expression levels of two other known MafAand MafB-activated gene targets, Slc30a8 and Glut2 (5, 22) , were also only transiently compromised in neonatal MafB ⌬panc islets (Fig. 2E) .
Our results indicate that embryonic loss of MafB delays islet ␤-cell maturation. Consequently, we analyzed whether GSIS was compromised in 2-wk-old compared with 8-wkold MafB ⌬panc islets (Fig. 3A) , when essentially no MafB ϩ ␤-or ␣-cells were present (data not shown). Insulin secretion was slightly elevated under nonstimulating 2.8 mM glucose conditions in 2-wk-old MafB ⌬panc islets, a basal secretion pattern of immature ␤-cells (8, 24, 36) . Conversely, the insulin secretion profile was normal in 8-wk-old MafB ⌬panc islets. MafB ⌬panc and control mice also had indistinguishable blood glucose tolerance profiles at 3, 6, and 8 wk (Fig. 1C) . In addition, the expression levels of a variety of MafA-and MafB-regulated genes were similar ) islets. In B, the ratio of 1 mM glucose to 1 mM glucose ϩ 10 mM Arg is 3.5 in MafB fl/fl and 1.6 in MafB ⌬panc . *P Ͻ 0.05, ***P Ͻ 0.001, and ****P Ͻ 0.0001, basal vs. stimulating conditions (n ϭ 4 -6). C: glucagon and ghrelin mRNA levels are selectively reduced in 8-wk-old MafB ⌬panc islet ␣-cells (n Ն 4). In contrast, many other ␣-cell, ␤-cell, and islet control factors are unchanged. *P Ͻ 0.05 compared with MafB fl/fl controls.
to controls in 8-wk-old MafB ⌬panc islets, including insulin, Nkx6.1, Glut2, Pdx1, and Slc30a8 (Fig. 3C) .
MafB is important to -cell ghrelin expression. Interestingly, glucagon and ghrelin mRNA levels were decreased significantly in 8-wk-old MafB ⌬panc islets, whereas somatostatin, pancreatic polypeptide, and insulin levels were similar to controls (Fig. 3C) . The impact on glucagon expression was not surprising, since MafB binds to and activates at the G1 element found between Ϫ71 and Ϫ55 base pairs relative to the transcription start site (6) . In contrast, it is unclear how MafB regulates ghrelin expression. Unfortunately, we could not determine whether there was a change in ghrelin staining levels due to the very few ε-cells in adult MafB fl/fl or MafB ⌬panc islets. Immunostaining confirmed that MafB is present in wild-type ghrelin ϩ cells at P1 (Fig. 4) , when ε-cells make up a small but larger proportion of the islet cell population than in the adult (34) . There was no obvious change in the P1 islet ghrelin cell population (Fig. 4) . Interestingly, MafB expression was observed in the gut but not in ghrelin ϩ cells (Fig. 5) , the principal location of this hormone-expressing population.
MafB is important to islet ␣-cell function. Glucose-stimulated glucagon secretion was measured in 8-wk-old MafB ⌬panc islets to determine whether secretion capacity was altered. Both glucagon content (Fig. 3B ) and ␣-cell numbers (Fig. 1B) were unchanged from controls, although glucagon secretion was reduced in MafB ⌬panc islets upon exposure to a stimulating low glucose concentration and the potent secretagogue, arginine (Fig. 3B ). There were no changes in islet ␣-cell-enriched transcription factors [i.e., Arx (13) and Brn4 (22a)] or several other ␣-cell-enriched gene products in MafB ⌬panc islets [i.e., HigD1a, Ndst4, Pdk4, and Ptprd (15); Fig. 3C ]. These analyses demonstrate that MafB controls postnatal islet ␣-cell function, which is quite interesting considering that MAFB levels are reduced in T2DM islet ␣-cells and glucagon secretion is dysregulated in this state (19, 43) . (Fig. 6B) , whereas total Pax6 ϩ endocrine cell numbers were unchanged. Note that very few Pax6 ϩ cells produce either insulin or glucagon in MafAB ⌬panc islets (i.e., ϳ75% change in hormone ϩ cell numbers; Fig. 6 , B and C). However, ␤-cell-enriched Nkx6.1 ϩ and Pdx1 ϩ cell numbers were decreased by only ϳ25% (Fig. 6D) . These results suggest that MafA and MafB are the principal drivers of insulin gene expression and not Nkx6.1 (38) and Pdx1 (31) . The overall developmental impact on hormone and transcription factor levels was comparable between MafAB ⌬panc and MafB Ϫ/Ϫ (3) mice. Collectively, these data demonstrate not only that the combined actions of MafA and MafB are required for postnatal ␤-cell formation but that MafB alone (unlike MafA) has little (if any) impact on mouse ␤-cells.
Loss of MafA and MafB in islet cells results in death soon
MAFB is expressed in NHP islet ␤-cells, with islet architecture and cell function analogous to human.
Human islets are dissimilar to mice in several ways, including the presence of MAFB in human ␤-cells, GSIS properties, and islet cell composition and distribution (9, 11, 14) . We next determined whether these islet properties were shared with NHPs. Like humans, MAFB was present in ␤-cells as well as ␣-cells (Fig.  7, A and B) . MAFB mRNA expression was relatively high in NHP and human islets compared with mice, whereas NHP MAFA was present at a level similar to mice (Fig. 7A) . PDX1 and pan-endocrine NEUROD1 transcription factor levels were comparable across species.
The relative mRNA levels of NHP INSULIN, GLUCA-GON, and SOMATOSTATIN were similar to human islet levels (Fig. 7D ). The differences in INSULIN, GLUCAGON, and ␣-cell-enriched ARX (Fig. 7A ) transcription factor levels with mice closely correlated with the increased proportion of ␣-cells in human and NHP islets, with fewer ␤-cells and more ␣-cells in primates (Fig. 7E) (9) . Moreover, the distribution of human (9) and NHP ␣-, ␤-, and ␦-cells was scattered throughout the islet, which was different from mouse islets where the ␣-and ␦-cells surround the ␤-cellrich core (Fig. 7E) . Insulin secretion from NHP and human islets was indistinguishable at 5.6, 16.7, and 16.7 mmol/l glucose plus IBMX and significantly different from mouse islets (Fig. 8) . The higher basal and lower insulin secretion response to high glucose is a defining feature of human and NHP islets. These results suggest that MAFB expression in islet ␤-cells represents a unique feature of the primate islet and is consequential to cell function.
DISCUSSION
Mouse MafA and/or MafB were removed specifically in early pancreatic progenitor cells to obtain insight into the contribution of MafB individually and MafA and MafB in combination with postnatal islet ␤-and ␣-cells. Only transient deficiencies in MafB ⌬panc ␤-cell activity were found, although adult islet ␣-cell glucagon secretion levels as well as ghrelin mRNA were compromised. Compensation by MafA likely explains the limited effect on MafB ⌬panc ␤-cells, which is supported by the tight expression linkage with mutant insulin ϩ cells (Fig. 2) . This proposal is also consistent with the substantially reduced islet insulin ϩ cell population in MafAB ⌬panc islets, which caused overt hyperglycemia and death. We conclude that MafB is essential only to postnatal mouse ␣-cell activity. This seems paradoxical since MAFB in human islet ␤-cells represents a unique transcription factor signature. Here we show that NHP islet ␤-cells also produce MAFB, and islet cell composition and ␤-cell function are essentially equivalent to that of humans. MafB was broadly expressed in the P1 duodenum (Fig. 5) , wherein a variety of metabolically interesting hormones are produced [e.g., cholecystokinin (CCK), gastric inhibitory peptide (GIP), glucagon-like peptide-1 (GLP-1), and ghrelin] (18). Notably, MafB was not expressed in ghrelin ϩ cells in the duodenum, presumably because these cells are not derived from Ngn3 ϩ progenitors (23), as in the pancreas. With this consideration, it will be of interest to determine whether MafB is necessary for regulating Ngn3-derived CCK, GIP, and/or GLP-1 expression, with positive results supporting a wider role for MafB in defining cell identity decisions.
Notably, whereas MafA and MafB influence transcription of genes associated with glucose sensing and hormone secretion in mouse islet ␣-and ␤-cells (5, 22) , both have distinct effects on cell activity (1, 5) and hormone gene expression (4) . For example, induction of glucose-responsive insulin secretion is obtained upon misexpression of MafA in neonatal rat islets, with high MafB expression associated with immature rodent GSIS properties (1). Amino acid differences within the NH 2 - Protein alignment and %identity of human MAFA and MAFB was determined using the EMBOSS Matcher tool. Amino acids of the transactivation domain are aligned below with residues that are common between the 2 proteins highlighted in gray. Amino acids 76 -108 of human MAFA are not present in human MAFB. D: the endocrine hormone mRNA expression pattern is analogous between human and NHP islets, whereas mouse is different. NHP (n ϭ 5), human (n ϭ 10), and mouse (C57BL/6J) (n ϭ 6) islets. *P Ͻ 0.05, **P Ͻ 0.01, and ***P Ͻ 0.001, mouse vs. human; ϩP Ͻ 0.05 and ϩϩP Ͻ 0.01, mouse vs. NHP. No significant difference seen between NHP and human (P Ͼ 0.05). E: representative image of a NHP and mouse (C57BL/6J) islet; Ins (green), Gluc (red), and somatostatin (SOM, blue). Scale bars, 100 m.
terminal transactivation domain and COOH-terminal spanning basic leucine zipper DNA-binding/dimerization region likely contribute to the distinct functions of each of these proteins (see Fig. 7C ). For example, exchanging the COOH-terminal region of MafA with MafB enabled this chimera to activate insulin levels in chick in ovo electroporation assays (4). Consequently, the increased level of MAFB in primate ␤-cells could contribute to differences in insulin secretion levels in rodents islets (Fig. 8) (14) . Importantly, recent evidence suggests that both MAFA and MAFB mediate GSIS in human ␤-cells (41). Thus, insulin secretion was compromised upon reducing the levels of either MAFA or MAFB in human EndoC-␤H1 cells. Furthermore, candidate gene analysis demonstrated that several genes important to human ␤-cell activity were regulated by MAFA and MAFB, but only MAFB activated SLC2A1 (GLUT1) levels, the primary glucose transporter of human ␤-cells. Future efforts will be focused on obtaining a better understanding of how MAFA and MAFB control human islet ␤-and ␣-cell functions.
Our data suggest that reduced MAFB levels in islet ␣-cells would contribute to the dysregulated glucagon secretion associated with T2DM patients (44) . However, we predict that T2DM ␣-cell dysfunction does not derive solely from MAFB loss but rather from a compilation of changes that occur in the islet populations, including counterregulatory insulin signaling to the ␣-cell. It will be of value to explore the mechanism(s) by which MAFB controls glucagon secretion and whether these are dysregulated in diabetic islet ␣-cells. 30; B) , and C57 mouse (n ϭ 12; C) islets in perifusion assays. D: basal insulin secretion levels. E and F: area under the curve (AUC) analysis of the 16.7 mM glucose (E) and 16.7 mM glucose ϩ IBMX (F) data. ***P Ͻ 0.001, mouse vs. human; ϩP Ͻ 0.05 and ϩϩϩ P Ͻ 0.001, mouse vs. NHP. No significant differences were found between NHP and human. G, glucose. IEQ, islet equivalent.
